Title:
COMPOSITION FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND ATOPIC DERMATITIS
Document Type and Number:
WIPO Patent Application WO/2017/065495
Kind Code:
A2
Abstract:
The present invention relates to a compound for inhibiting the secretion of thymic stromal lymphopoietin (TSLP) from mast cells, and a use thereof. It has been confirmed that the compound of the present invention significantly inhibits the secretion of TSLP from mast cells, and thus the compound can be used as a candidate material for the treatment and prevention of atopic dermatitis, allergic dermatitis and/or inflammatory bowel disease.
Inventors:
KANG IN CHEOL (KR)
Application Number:
PCT/KR2016/011434
Publication Date:
April 20, 2017
Filing Date:
October 12, 2016
Export Citation:
Assignee:
INNOPHARMASCREEN INC (KR)
International Classes:
C07C279/26; A23L33/10; A61K8/43; A61K8/46; A61K31/155; A61K31/167; A61K31/18; C07C233/06; C07C279/18; C07C311/21
Other References:
See references of EP 3363783A4
Attorney, Agent or Firm:
PINNACLE IP & LAW FIRM (KR)
Download PDF:
Previous Patent: PORTABLE DEVICE AND SCREEN DISPLAY METHOD OF PORTABLE DEVICE
Next Patent: BATTERY PACK
Next Patent: BATTERY PACK